CBPO China Biologic Products Inc.
IndustryBiotechnology: Biological Products (No Diagnostic Substances)
- 26.8 P/E
- 7.36 P/S
- 8.64 P/B
- 2.538 EPS
- 40.69% Cash ROIC
- 2.38 Cash Ratio
- 0 / 0% Dividend
- 66,903.00 Avg. Vol.
- 27.57M Shares
- 1.665B Market Cap.
China Biologic Products, Inc., a biopharmaceutical company, engages in the research, development, production, and manufacture of plasma-based pharmaceutical products in the People's Republic of China. It offers Human Albumin for the treatment of shock caused by blood loss trauma or burn; raised intracranial pressure caused by hydrocephalus or trauma; oedema or ascites caused by hepatocirrhosis and...
Seeking Alpha (registration) - Nov 6, 2014
Jefferies Group Reaffirms "Buy" Rating for China Biologic Products (CBPO) - Ticker Report
Zacks.com - Aug 27, 2014
Forbes - Oct 13, 2014
Zacks.com - Nov 11, 2014
Zacks.com - Jul 9, 2014
Seeking Alpha (registration) - Aug 5, 2014
PR Newswire (press release) - Nov 3, 2014
Seeking Alpha (registration) - Sep 22, 2014
Zacks.com - Aug 19, 2014
MSN Money - Apr 24, 2014